These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19776771)

  • 1. Dialysis: vascular access: not enough light at the end of the tunnel?
    Vanholder R; Verbeke F; Van Biesen W
    Nat Rev Nephrol; 2009 Oct; 5(10):551-2. PubMed ID: 19776771
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic agents and the prevention of access thrombosis.
    Kaufman JS
    Semin Dial; 2000; 13(1):40-6. PubMed ID: 10740671
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular access thrombosis--what are the possibilities of intervention?
    Mysliwiec M
    Nephrol Dial Transplant; 1997 May; 12(5):876-8. PubMed ID: 9175037
    [No Abstract]   [Full Text] [Related]  

  • 4. Reducing the risk of hemodialysis access.
    Schwab SJ
    Am J Kidney Dis; 1999 Aug; 34(2):362-3. PubMed ID: 10430989
    [No Abstract]   [Full Text] [Related]  

  • 5. Regarding "Endovascular versus surgical treatment for thrombosed hemodialysis: a prospective, randomized study".
    Farner MC
    J Vasc Surg; 2000 Nov; 32(5):1038-9. PubMed ID: 11054238
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.
    Diskin CJ; Stokes TJ; Pennell AT
    Nephron; 1993; 64(1):1-26. PubMed ID: 8502311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodialysis access--a vascular surgical problem].
    Hedin U
    Lakartidningen; 2011 Feb 23-Mar 1; 108(8):406-10. PubMed ID: 21485475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antithrombotic therapy].
    Zahn R
    Herz; 2014 Nov; 39(7):789. PubMed ID: 25336241
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombosis of the vascular access in hemodialysis patients. Rationale for the preventive use of olive oil].
    Villarrubia VG; Gil-Cunquero JM; Pérez-Bañasco V
    Nefrologia; 2007; 27(2):122-33. PubMed ID: 17564556
    [No Abstract]   [Full Text] [Related]  

  • 10. Clopidogrel diminishes hemodialysis access graft thrombosis.
    Trimarchi H; Young P; Forrester M; Schropp J; Pereyra H; Freixas E
    Nephron Clin Pract; 2006; 102(3-4):c128-32. PubMed ID: 16282697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clopidogrel on arteriovenous fistulas for dialysis.
    Wusirika R; Rao P
    JAMA; 2008 Oct; 300(14):1647; author reply 1648-9. PubMed ID: 18840831
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
    Al Shakarchi J; Inston N; Jones RG; Maclaine G; Hollinworth D
    J Vasc Surg; 2016 Apr; 63(4):1026-33. PubMed ID: 26826055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clopidogrel on arteriovenous fistulas for dialysis.
    Fourtounas C; Vlachojannis JG
    JAMA; 2008 Oct; 300(14):1648; author reply 1648-9. PubMed ID: 18840832
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between gender and vascular access complications in hemodialysis patients.
    Astor BC; Coresh J; Powe NR; Eustace JA; Klag MJ
    Am J Kidney Dis; 2000 Dec; 36(6):1126-34. PubMed ID: 11096036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case against chronic venous hemodialysis access.
    Butterly D; Schwab SJ
    J Am Soc Nephrol; 2002 Aug; 13(8):2195-7. PubMed ID: 12138157
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in end-stage renal diseases 2000. Access monitoring methods.
    Besarab A
    Blood Purif; 2000; 18(4):255-9. PubMed ID: 10965064
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular access for haemodialysis: an unresolved issue].
    Roca Tey R
    Nefrologia; 2010; 30(3):280-7. PubMed ID: 20514096
    [No Abstract]   [Full Text] [Related]  

  • 19. Editor's Choice - Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).
    Schmidli J; Widmer MK; Basile C; de Donato G; Gallieni M; Gibbons CP; Haage P; Hamilton G; Hedin U; Kamper L; Lazarides MK; Lindsey B; Mestres G; Pegoraro M; Roy J; Setacci C; Shemesh D; Tordoir JHM; van Loon M; Esvs Guidelines Committee ; Kolh P; de Borst GJ; Chakfe N; Debus S; Hinchliffe R; Kakkos S; Koncar I; Lindholt J; Naylor R; Vega de Ceniga M; Vermassen F; Verzini F; Esvs Guidelines Reviewers ; Mohaupt M; Ricco JB; Roca-Tey R
    Eur J Vasc Endovasc Surg; 2018 Jun; 55(6):757-818. PubMed ID: 29730128
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin and arteriovenous graft thrombosis in hemodialysis: just what the doctor ordered?
    Bech FR; Chertow GM
    J Am Soc Nephrol; 2011 Apr; 22(4):595-7. PubMed ID: 21415154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.